EBURY
SACE SIMEST, the export and internationalisation hub of Cassa Depositi e Prestiti Group, and Ebury, one of Europe's leading Fintech companies offering global transaction banking services to businesses, have signed a partnership which will facilitate access, especially for SMEs, to a number of insurance and financial solutions that can improve their international competitiveness.
Thanks to this collaboration, Italian exporters will have access to a range of highly digitized services for 360° protection of all risks related to international operations. The integrated service will give Italian SMEs protection against credit risk (via products from SACE SIMEST) and FX risk in over 130 currencies (via Ebury’s services).
“The partnership with Ebury allows us to offer to Italian SMEs innovative, transparent and competitive solutions in order to manage the volatility of foreign currencies, a very important variable for all those companies, especially the smaller ones, which trade with international markets – said Alessandro Decio, CEO of SACE - We are creating a digital platform, innovative and easy to access, where we wish to include also other important Fintech, like Ebury, with the aim to bring an increasing number of Italian companies to export all over the world, fully unleashing their potential. We are convinced that this is the first of further agreements with other Fintech, that operate in a complementarity way to SACE SIMEST, and that can increase support and competitiveness to the export of Italian SMEs.”
Juan Lobato, co-founder and CEO of Ebury , added, "Ebury’s mission is to help SMEs to grow in the global market, both by working directly with them as well as by collaborating with other leading financial institutions. With this strategic partnership, SACE SIMEST gets to the forefront of the collaboration between Export Credit Agencies and innovative Fintech companies: we are honoured to work with such an important institution to support the global growth of Italian businesses ". Paolo Giabardo, Chief Commercial Officer at Ebury , continued “We are really excited about the partnership with SACE SIMEST and how this will expand our support to Italian SMEs. This partnership is further validation of the effectiveness of our business model in providing transactional services to small and medium enterprises competing in the global market”.
For Italian businesses, the joint offer will also improve liquidity management and simplify international transactions, combining the services of SACE SIMEST, aimed at optimizing working capital, with the offer provided by Ebury, which aims to make international collections more efficient by offering currency accounts in more than 30 currencies and in more than 20 countries.
This is one of the first partnerships in Europe between an Export Credit Agency and a Fintech company and it represents a further milestone in the digital transformation process implemented by SACE SIMEST.
Finally, this collaboration will support Italian SMEs with an increased awareness of their exposure to currency volatility, access to dedicated specialists and world leading insurance and financial services to support their international growth.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190918005819/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 14:00:00 CEST | Press release
Pivotal Study Advances to Establish Histotripsy as a Non-Thermal, Surgery-Free Alternative to Destroy and Liquefy Kidney Tumors HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison
Norwegian Tech Firm Builds Military Command Center in 24 Hours6.6.2025 13:45:00 CEST | Press release
Norwegian technology provider Cyviz has successfully developed a fully mobile and ballistic-proof command center - designed, configured, and made operational in just 24 hours. The solution was showcased during a military exercise led by the Dutch Ministry of Defence and has already sparked interest from NATO members and civil protection agencies across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606640770/en/ Cyviz demonstrates rapid deployment capability with a mobile, container-based control room for defense and crisis response Cyviz and its partners constructed the command room inside a 14-ton container designed for transport on standard military vehicles and resistant to machine gun fire. The unit was deployed at a military base in the Netherlands, where Cyviz was tasked with delivering a fully functional command-and-control environment, under strict time constraints and in a high-stakes simulation. "You do
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom